Zyprexa Labels May Need Stronger Warning
-August 6, 2008
According to reports, the current warnings on Eli Lily & Co’s labels for Zyprexa may need to be stronger.
Court documents claim the current labels may not do a sufficient job in warning patients of the risks linked to the antipsychotic.
Labels Updated in 2007
In October 2007, Lily added a warning to its packaging informing the public of the risk of weight gain associated with the medication.
More than half of patients in 13 studies gained 12 an average of 12 pounds after being on Zyprexa for less than a year.
The current labels explain that those taking the drug are at risk for very high blood-sugar levels.
Updated Labels Suggested
A recent letter written to Eli Lily suggests the labels be updated to link Zyprexa more directly to high blood-sugar and diabetes.
The letter reportedly stems for a lawsuit filed in Alaska claiming the drug manufacturers withheld information regarding the risks of the drug.
“We believe that it is in the best interest of the public health to make interim labeling changes now based on the data that we already have,” states the letter.
Has your health been put at risk due to Zyprexa? If so, please contact us today to speak with an experienced attorney who will evaluate your case and ensure you are rightfully compensated for any wrongdoing..